Potato Starch Market Size to be Worth USD 9.1 billion by 2031, with Notable CAGR of 4.9%| Transparency Market Research, Inc.
02 janv. 2024 10h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Potato starch market was valued at US$ 5.9 billion in 2022. It is expected to expand at a...
Leading Hub Services Provider COPILOT Appoints Valerie Sullivan as Chief Commercial Officer
19 déc. 2023 11h35 HE
|
COPILOT Provider Support Services
LEADING HUB SERVICES PROVIDER COPILOT APPOINTS VALERIE SULLIVAN AS CHIEF COMMERCIAL OFFICER
Related Sciences Adds 8 New Senior Advisors Including Former CEOs and Heads of R&D from Genentech, Novartis, Seagen, Pfizer, Celgene, and AstraZeneca
19 déc. 2023 10h00 HE
|
Related Sciences
Former CEOs and executives from Genentech, Novartis, Seagen, Pfizer, and Celgene join drug AI/ML drug discovery firm Related Sciences as senior advisors.
Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innovation Fund and ARTIS Ventures
19 déc. 2023 09h00 HE
|
Unnatural Products
Santa Cruz, CA, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech company pairing AI with chemistry to usher in the next generation of molecularly targeted therapeutics,...
23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts
19 déc. 2023 08h00 HE
|
23andMe, Inc.
Thirty additional patients with advanced neuroendocrine and advanced ovarian cancer will be enrolled in the study of 23ME-00610, an investigational antibody targeting CD200R1 A second potentially...
Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens
18 déc. 2023 07h00 HE
|
Replay Bio
Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens Replay and its...
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy®
18 déc. 2023 07h00 HE
|
Replay Bio
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy® Syena...
First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company
18 déc. 2023 06h00 HE
|
First Wave BioPharma, Inc.
Phase 3-ready latiglutenase, a targeted oral biotherapeutic for celiac disease, will expand First Wave BioPharma’s late-stage gastrointestinal (GI) disease clinical pipeline A concurrent...
Actuators and Valves Market Size to Exceed USD 615.6 million By 2031, with a Robust CAGR of 4.3%| States Transparency Market Research, Inc.
15 déc. 2023 04h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The actuators and valves market was worth US$ 415.3 million in 2022. A CAGR of 4.3% is...
BMS Attributes Sotyktu Falling Short of Growth Expectations to Access, but Recent Spherix Global Insights’ Data Suggest Safety Concerns Are More of a Barrier to Increased Uptake
07 déc. 2023 12h01 HE
|
Spherix Global Insights
Exton, PA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- While access took the forefront of BMS’ response to Sotyktu (deucravacitinib) not meeting growth expectations during the company’s Q3 earnings call,...